PMGC (ELAB) vs Jupiter Neurosciences (JUNS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Jupiter Neurosciences is the larger company by market cap ($1.6 million vs $1.3 million), about 1.2 times the size. PMGC converts more of its revenue into profit, with a net margin of -1313.0% versus -39662.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAB | JUNS |
|---|---|---|
| Share price | $1.14 | $1.24 |
| Market cap | $1.33M | $1.63M |
| 1-day change | -10.24% | -18.75% |
| Forward P/E | — | 20.58 |
| EPS (TTM) | $-555.60 | $-22.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $590.08K | $21.80K |
| Net income (latest FY) | $-7.75M | $-8.64M |
| Gross margin | 31.40% | 80.59% |
| Operating margin | — | -40873.19% |
| Net margin | -1313.00% | -39662.77% |
| 52-week high | $1,344.00 | $97.73 |
| 52-week low | $1.14 | $1.20 |
| Distance from 52-week high | -99.92% | -98.74% |
| Average volume | 279.01K | 69.86K |
| Shares outstanding | 1.17M | 1.32M |
| Employees | 32 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMGC is more profitable, keeping -1313.0 cents of every revenue dollar as net income versus -39662.8 cents for Jupiter Neurosciences.
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
About Jupiter Neurosciences
JUNS stock →Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
ELAB vs JUNS FAQ
Which is bigger, PMGC or Jupiter Neurosciences?
Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $1.63M compared with $1.33M for PMGC (ELAB).
Are PMGC and Jupiter Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.